Reactive Oxygen Species and Dopamine Receptor Function in Essential Hypertension

References

• Ruilope L, Kjeldsen SE, de la Sierra A, Mancia G, Ruggenenti P, Stergiou GS, Bakris GL, Giles TD. The kidney and cardiovascular risk – implications for management: A consensus statement from the European Society of Hypertension. Blood Press 2007; 16: 72–79
   PubMed Web of Science ®Google Scholar
• Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004; 26: 731–738
   PubMed Web of Science ®Google Scholar
• Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206
   PubMed Web of Science ®Google Scholar
• Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85: 679–715
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA. The dopaminergic system in hypertension. Clin Sci (London) 2007; 112: 583–597
   PubMed Web of Science ®Google Scholar
• Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228: 134–142
   PubMed Web of Science ®Google Scholar
• Carey RM. Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001; 38: 297–302
   PubMed Web of Science ®Google Scholar
• Amenta F, Ricci A, Rossodivita I, Avola R, Tayebati SK. The dopaminergic system in hypertension. Clin Exp Hypertens 2001; 23: 15–24
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006; 71: 247–258
   PubMed Web of Science ®Google Scholar
• Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension?. Am J Physiol Regul Integr Comp Physiol 2005; 289: R913–R935
   PubMed Web of Science ®Google Scholar
• Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007; 49: 717–727
   PubMed Web of Science ®Google Scholar
• White BH, Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: A mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens 1998; 16: 1659–1665
   PubMed Web of Science ®Google Scholar
• Fardoun RZ, Asghar M, Lokhandwala M. Role of oxidative stress in defective renal dopamine D1 receptor-G protein coupling and function in old Fischer 344 rats. Am J Physiol Renal Physiol 2006; 291: F945–F951
   PubMed Web of Science ®Google Scholar
• Marwaha A, Banday AA, Lokhandwala MF. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2004; 286: F451–F457
   PubMed Web of Science ®Google Scholar
• Wilcox CS, Gutterman D. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2005; 288: H3–H6
   PubMed Web of Science ®Google Scholar
• Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 2008; 283: 15539–15543
   PubMed Web of Science ®Google Scholar
• Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR, Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008; 299: 2287–2293
   PubMed Web of Science ®Google Scholar
• Boyden PA, Davies SS, Viswanathan PC, Amarnath V, Balser JR, Roberts LJ. Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias. J Cardiovasc Pharmacol 2007; 50: 480–486
   PubMed Web of Science ®Google Scholar
• Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813–839
   PubMed Web of Science ®Google Scholar
• Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006; 55: 928–934
   PubMed Web of Science ®Google Scholar
• Tanaka M, Umemoto S, Kawahara S, Kubo M, Itoh S, Umeji K, Matsuzaki M. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 67–77
   PubMed Web of Science ®Google Scholar
• Abraham NG, Asija A, Drummond G, Peterson S. Heme oxygenase -1 gene therapy: Recent advances and therapeutic applications. Curr Gene Ther 2007; 7: 89–108
   PubMed Web of Science ®Google Scholar
• Maines MD. The heme oxygenase system: Update 2005. Antioxid Redox Signal 2005; 7: 1761–1766
   PubMed Web of Science ®Google Scholar
• Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002; 40: 511–515
   PubMed Web of Science ®Google Scholar
• Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 2003; 285: H2345–H2354
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 2003; 93: 573–580
   PubMed Web of Science ®Google Scholar
• Makino A, Skelton MM, Zou AP, Cowley AW, Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 2003; 42: 25–30
   PubMed Web of Science ®Google Scholar
• Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87: 245–313
   PubMed Web of Science ®Google Scholar
• Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8: 1597–1607
   PubMed Web of Science ®Google Scholar
• Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691–728
   PubMed Web of Science ®Google Scholar
• Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 2007; 49: 672–678
   PubMed Web of Science ®Google Scholar
• Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50: 62–68
   Google Scholar
• Li H, Witte K, August M, Brausch I, Godtel-Armbrust U, Habermeier A, Closs EI, Oelze M, Munzel T, Forstermann U. Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol 2006; 47: 2536–2544
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yasunari K, Nakamura M, Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens 2006; 20: 336–340
   PubMed Web of Science ®Google Scholar
• Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41: 341–346
   PubMed Web of Science ®Google Scholar
• Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension 2006; 48: 467–472
   PubMed Web of Science ®Google Scholar
• Han HJ, Park SH, Park KM, Yoon BC, Kim TS, Lee JH. Effect of caffeic acid on apical transporters’ dysfunction of renal proximal tubule cells under oxidative stress in vitro. Planta Med 2002; 68: 483–486
   PubMed Web of Science ®Google Scholar
• Nowak G, Bakajsova D, Clifton GL. Protein kinase C-epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells. Am J Physiol Renal Physiol. 2004; 286: F307–F316
   PubMed Web of Science ®Google Scholar
• Pedrosa R, Villar VA, Pascua AM, Simão S, Hopfer U, Jose PA, Soares-da-Silva P. H2O2 stimulation of the Cl-/HCO3- exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension 2008; 51: 1332–1338
   PubMed Web of Science ®Google Scholar
• Banday AA, Fazili FR, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kappaB and protein kinase C. J Am Soc Nephrol 2007; 18: 1446–1457
   PubMed Web of Science ®Google Scholar
• Garvin JL, Ortiz PA. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol Scand 2003; 179: 225–232
   PubMedGoogle Scholar
• Kojsova S, Jendekova L, Zicha J, Kunes J, Andriantsitohaina R, Pechanova O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 2006; 55: S3–S16
   PubMed Web of Science ®Google Scholar
• Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, Heidland A, Stopper H. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol 2007; 292: F1427–F1434
   PubMed Web of Science ®Google Scholar
• Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1472–R1478
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004; 44: 248–252
   PubMed Web of Science ®Google Scholar
• Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954–1962
   PubMed Web of Science ®Google Scholar
• Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG. Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 2002; 16: 333–336
   PubMed Web of Science ®Google Scholar
• Lee VM, Quinn PA, Jennings SC, Ng LL. NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models. Hypertension 2003; 41: 925–931
   PubMed Web of Science ®Google Scholar
• Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft KD. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med 2004; 36: 226–232
   PubMed Web of Science ®Google Scholar
• Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41: 1096–1101
   PubMed Web of Science ®Google Scholar
• Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, Degan M, Faccini G, Fornasiero A, Talamini G, Tommasoli R, Arosio E, Santonastaso CL, Lechi A, Patrono C. Determinants of platelet activation in human essential hypertension. Hypertension 2004; 43: 64–70
   PubMed Web of Science ®Google Scholar
• Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 2003; 41: 286–288
   PubMed Web of Science ®Google Scholar
• Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101: 1530–1537
   PubMed Web of Science ®Google Scholar
• Li Z, Yu C, Han Y, Ren H, Shi W, Fu C, He D, Huang L, Yang C, Wang X, Zhou L, Asico LD, Zeng C, Jose PA. Inhibitory Effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2008; 294(6)H2761–H2768
   PubMed Web of Science ®Google Scholar
• O'Connell DP, Aherne AM, Lane E, Felder RA, Carey RM. Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol 1998; 274: F232–F241
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Jose PA, Carey RM, Felder RA. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 1997; 29: 962–968
   PubMed Web of Science ®Google Scholar
• Kim MO, Koh PO, Kim JH, Kim JS, Kang SS, Cho GJ, Kim K, Choi WS. Localization of dopamine D1 and D2 receptor mRNAs in the rat systemic and pulmonary vasculatures. Mol Cells 1999; 9: 417–421
   PubMed Web of Science ®Google Scholar
• Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19: 233–246
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Felder RA, Carey RM. Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension 1999; 33: 504–510
   PubMed Web of Science ®Google Scholar
• Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am J Hypertens 2000; 13: 156A, abstract
   Google Scholar
• Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97: 2283–2288
   PubMed Web of Science ®Google Scholar
• Nishi A, Eklöf AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na+,K+-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993; 21: 767–771
   PubMed Web of Science ®Google Scholar
• Pedrosa R, Jose PA, Soares-Da-Silva P. Defective D1-like receptor-mediated inhibition of Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 2004; 286: F1120–F1126
   PubMed Web of Science ®Google Scholar
• Xu J, Li XX, Albrecht FE, Hopfer U, Carey RM, Jose PA. D1 receptor, Gsα, and Na+/H+ exchanger interactions in the kidney in hypertension. Hypertension 2000; 36: 395–399
   PubMed Web of Science ®Google Scholar
• Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol 2003; 473: 185–190
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Kobayashi Y, Shimoura K, Hattori K, Nakase A. Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol. 1992; 19: 401–410
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang D, Asico LD, Welch WJ, Wilcox CS, Hopfer U, Eisner GM, Felder RA, Jose PA. Aberrant D1 and D3 dopamine receptor transregulation in hypertension. Hypertension 2004; 43: 654–660
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang D, Yang Z, Wang Z, Asico LD, Wilcox CS, Eisner GM, Welch WJ, Felder RA, Jose PA. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 2004; 43: 673–679
   PubMed Web of Science ®Google Scholar
• White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO. cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BKCa channel activity in coronary artery smooth muscle cells. Circ Res 2000; 86: 897–905
   PubMed Web of Science ®Google Scholar
• Natarajan AR, Han G, White R, Jose PA. The human D5 dopamine receptor mediates big KCa channel activity in human coronary artery smooth muscle cells. Hypertension 2006; 48: e80
   PubMed Web of Science ®Google Scholar
• Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990; 15: 560–569
   PubMed Web of Science ®Google Scholar
• Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A 1992; 14: 615–628
   PubMed Web of Science ®Google Scholar
• Kunimi M, Seki G, Hara C, Taniguchi S, Uwatoko S, Goto A, Kimura S, Fujita T. Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 2000; 57: 534–543
   PubMed Web of Science ®Google Scholar
• Yu P, Asico LD, Luo Y, Andrews P, Eisner GM, Hopfer U, Felder RA, Jose PA. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 2006; 70: 1072–1079
   PubMed Web of Science ®Google Scholar
• Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33: 1036–1042
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84: 1849–1856
   PubMed Web of Science ®Google Scholar
• Hussain T, Lokhandwala MF. Renal dopamine DA1 receptor coupling with GS and Gq/11 proteins in spontaneously hypertensive rats. Am J Physiol 1997; 272: F339–F346
   PubMed Web of Science ®Google Scholar
• Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345: 1548–1557
   PubMed Web of Science ®Google Scholar
• Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J Clin Endocrinol Metab 1989; 69: 1116–1121
   PubMed Web of Science ®Google Scholar
• Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol 1993; 265: F845–F852
   PubMed Web of Science ®Google Scholar
• Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 1998; 7: 1379–1383
   PubMed Web of Science ®Google Scholar
• Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrmann SM, Burnier M, Brand E. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008; 51: 1643–1650
   PubMed Web of Science ®Google Scholar
• Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 2000; 36: 183–186
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhu H, Wang X, Snieder H, Huang Y, Harshfield GA, Treiber FA, Dong Y. Effects of dopamine receptor type 1 and Gs protein α subunit gene polymorphisms on blood pressure at rest and in response to stress. Am J Hypertens 2006; 19: 832–836
   PubMed Web of Science ®Google Scholar
• Banday AA, Lau YS, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008; 51: 367–375
   PubMed Web of Science ®Google Scholar
• Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655–673
   PubMed Web of Science ®Google Scholar
• Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids 1990; 41: 27–33
   PubMed Web of Science ®Google Scholar
• Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol 2003; 42: 82–88
   PubMed Web of Science ®Google Scholar
• Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens 2003; 16: 173–179
   PubMed Web of Science ®Google Scholar
• Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med. 2008; 86: 729–734
   PubMed Web of Science ®Google Scholar
• Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1-receptor-G-protein coupling and function in obese Zucker rats. Diabetes 2005; 54: 2219–2226
   PubMed Web of Science ®Google Scholar
• Marwaha A, Lokhandwala MF. Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats. Am J Physiol Renal Physiol 2006; 291: F58–F66
   PubMed Web of Science ®Google Scholar
• Fardoun RZ, Asghar M, Lokhandwala M. Role of nuclear factor kappa B (NF-κB) in oxidative stress-induced defective dopamine D1 receptor signaling in the renal proximal tubules of Sprague-Dawley rats. Free Radic Biol Med 2007; 42: 756–764
   PubMed Web of Science ®Google Scholar
• Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF. Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 2006; 40: 13–20
   PubMed Web of Science ®Google Scholar
• Han H, Arnaldo FB, Jose PA, Yu P. D1 Dopamine receptor down-regulates NADPH oxidase activity via a protein kinase C and protein kinase A cross-talk in human kidney cells. FASEB J 2008; 22: 969, abstract
   Google Scholar
• Amenta F. Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin Exp Hypertens 1997; 19: 27–41
   PubMed Web of Science ®Google Scholar
• Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA. Gα12- and Gα13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41: 604–610
   PubMed Web of Science ®Google Scholar
• Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614–619
   PubMed Web of Science ®Google Scholar
• Zeng C, Yang Z, Asico LD, Jose PA. Regulation of blood pressure by D5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 2007; 5: 241–248
   PubMedGoogle Scholar
• Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290: R96–R104
   PubMed Web of Science ®Google Scholar
• Yao LP, Huque E, Baraniuk J, Carey RM, Felder RA, Jose PA. Dopamine receptor subtype expression (D1A AND D1B) in rat nephron segments. J Invest Med 1996; 44: 305A, abstract
   Web of Science ®Google Scholar
• Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005; 90: 449–455
   PubMed Web of Science ®Google Scholar
• Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D1-like receptors. Circulation 2000; 101: 2302–2308
   PubMed Web of Science ®Google Scholar
• Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38: 773–778
   PubMed Web of Science ®Google Scholar
• Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 1999; 9: 199–206
   PubMedGoogle Scholar
• Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22: 10801–10810
   PubMed Web of Science ®Google Scholar
• Cosentino M, Rasini E, Colombo C, Marino F, Blandini F, Ferrari M, Samuele A, Lecchini S, Nappi G, Frigo G. Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med 2004; 36: 1233–1234
   PubMedGoogle Scholar
• Sam EE, Verbeke N. Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in Parkinsonism. J Neural Transm 1995; 10: 115–127
   Web of Science ®Google Scholar
• Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, Sibley DR, Felder RA, Jose PA. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005; 288: H55–H61
   PubMed Web of Science ®Google Scholar
• Huang P, Frohman MA. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007; 11: 707–716
   PubMed Web of Science ®Google Scholar
• Min DS, Lee KH, Chang JS, Ahn BH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. Altered expression of phospholipase D1 in spontaneously hypertensive rats. Mol Cells 2001; 11: 386–391
   PubMed Web of Science ®Google Scholar
• Yao LP, Li XX, Yu PY, Xu J, Asico LD, Jose PA. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998; 32: 1049–1053
   PubMed Web of Science ®Google Scholar
• Jackson A, Sedaghat K, Minerds K, James C, Tiberi M. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors. J Neurochem 2005; 95: 1387–1400
   PubMed Web of Science ®Google Scholar
• Li H, Altea JR, Jose PA, Yu P. A D1-like receptor inhibits reactive oxygen species production by interfering with the distribution and assembly of NAD(P)H oxidase components. Council for High Blood Pressure Research 2005; 151, abstract
   Google Scholar
• Han W, Villar VAM, Li H, Jose PA, Yu P. Differential targeting of NADPH oxidase to lipid rafts of renal proximal tubule cells. FASEB J 2007; 21: A358, abstract
   Google Scholar
• Lu Q, Asico LD, Jones JE, Yu P, Maines MD, Felder RA, Jose PA. D5 dopamine receptor regulation of ROS through heme-oxygenase. J Clin Hypertens 2007; 9(suppl A)A116, abstract
   Google Scholar
• Monsma FJ, Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 1989; 342: 926–929
   PubMed Web of Science ®Google Scholar
• Jomphe C, Tiberi M, Trudeau LE. Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 2006; 50: 595–605
   PubMed Web of Science ®Google Scholar
• Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A 2003; 100: 4305–4309
   PubMed Web of Science ®Google Scholar
• Gao DQ, Canessa LM, Mouradian MM, Jose PA. Expression of the D2 subfamily of dopamine receptor genes in kidney. Am J Physiol 1994; 266: F646–F650
   PubMed Web of Science ®Google Scholar
• Narkar VA, Hussain T, Pedemonte C, Lokhandwala MF. Dopamine D2 receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 2001; 12: 1844–1852
   PubMed Web of Science ®Google Scholar
• Cavallotti C, Nuti F, Bruzzone P, Mancone M. Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 2002; 29: 412–418
   PubMed Web of Science ®Google Scholar
• Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294: H551–H569
   PubMed Web of Science ®Google Scholar
• Ozono R, Ueda A, Oishi Y, Yano A, Kambe M, Katsuki M, Oshima T. Dopamine D2 receptor modulates sodium handling via local production of dopamine in the kidney. J Cardiovasc Pharmacol 2003; 42: S75–S79
   PubMed Web of Science ®Google Scholar
• Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 2007; 26: 2127–2036
   PubMed Web of Science ®Google Scholar
• Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 2001; 38: 303–308
   PubMed Web of Science ®Google Scholar
• Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 2003; 16: 853–858
   PubMed Web of Science ®Google Scholar
• Narkar VA, Hussain T, Lokhandwala MF. Activation of D2-like receptors causes recruitment of tyrosine-phosphorylated NKA alpha 1-subunits in kidney. Am J Physiol Renal Physiol 2002; 283: F1290–F1295
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Walk SF, Jose PA, Felder RA. Dopamine D2L receptors stimulate Na+/K+ ATPase activity in murine LTK2 cells. Mol Pharmacol 1996; 49: 373–378
   PubMed Web of Science ®Google Scholar
• Bertorello AM, Hopfield JF, Aperia A, Greengard P. Inhibition by dopamine of Na+-K+ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 1990; 347: 386–388
   PubMed Web of Science ®Google Scholar
• Bertorello A, Aperia A. Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol 1990; 259: F924–F928
   PubMed Web of Science ®Google Scholar
• Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 1991; 353: 164–167
   PubMed Web of Science ®Google Scholar
• Kanterman RY, Mahan LC, Briley EM, Monsma FJ, Jr, Sibley DR, Axelrod J, Felder CC. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 1991; 39: 364–369
   PubMed Web of Science ®Google Scholar
• Kirchheimer C, Mendez CF, Acquier A, Nowicki S. Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol 2007; 292: F1435–F1442
   PubMed Web of Science ®Google Scholar
• Eklof AC. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 1997; 160: 311–314
   PubMedGoogle Scholar
• Jose PA, Asico LD, Eisner GM, Pocchiari F, Semeraro C, Felder RA. Effects of costimulation of dopamine D1- and D2-like receptors on renal function. Am J Physiol 1998; 275: R986–R994
   PubMed Web of Science ®Google Scholar
• Barili P, Ricci A, Baldoni E, Mignini F, Amenta F. Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney. Eur J Pharmacol 1997; 338: 89–95
   PubMed Web of Science ®Google Scholar
• O'Connell DP, Vaughan CJ, Aherne AM, Botkin SJ, Wang ZQ, Felder RA, Carey RM. Expression of the dopamine D3 receptor protein in the rat kidney. Hypertension 1998; 32: 886–895
   PubMed Web of Science ®Google Scholar
• Luippold G, Kuster E, Joos TO, Muhlbauer B. Dopamine D3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 690–693
   PubMed Web of Science ®Google Scholar
• Zeng C, Asico LD, Yu C, Villar VAM, Shi W, Luo Y, Wang Z, He D, Liu Y, Huang L, Yang C, Wang X, Hopfer U, Eisner GM, Jose PA. Renal D3 dopamine receptor stimulation induces natriuresis by endothelin receptor interactions. Kidney Int 2008; 74(6)750–759
   PubMed Web of Science ®Google Scholar
• Luippold G, Zimmermann C, Mai M, Kloor D, Starck D, Gross G, Muhlbauer B. Dopamine D3 receptors and salt-dependent hypertension. J Am Soc Nephrol 2001; 12: 2272–2279
   PubMed Web of Science ®Google Scholar
• Zeng C, Eisner GM, Felder RA, Jose PA. D3 dopamine receptor and essential hypertension. Curr Hypertens Rev 2006; 2: 247–253
   Google Scholar
• Sun D, Wilborn TW, Schafer JA. Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am J Physiol 1998; 275: F742–F751
   PubMed Web of Science ®Google Scholar
• Ricci A, Marchal-Victorion S, Bronzetti E, Parini A, Amenta F, Tayebati SK. Dopamine D4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. Histochem Cytochem 2002; 50: 1091–1096
   PubMed Web of Science ®Google Scholar
• Ricci A, Mignini F, Tomassoni D, Amenta F. Dopamine receptor subtypes in the human pulmonary arterial tree. Auton Autacoid Pharmacol 2006; 26: 361–369
   PubMedGoogle Scholar
• Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A. Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 2000; 22: 277–288
   PubMed Web of Science ®Google Scholar
• Ricci A, Bronzetti E, Fedele F, Ferrante F, Zaccheo D, Amenta F. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart. J Auton Pharmacol 1998; 18: 115–121
   PubMedGoogle Scholar
• Gomez Mde J, Rousseau G, Nadeau R, Berra R, Flores G, Suarez J. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart. Can J Physiol Pharmacol 2002; 80: 578–587
   PubMed Web of Science ®Google Scholar
• Sun D, Schafer JA. Dopamine inhibits AVP-dependent Na+ transport and water permeability in rat CCD via a D4-like receptor. Am J Physiol 1996; 271: F391–F400
   PubMed Web of Science ®Google Scholar
• Saito O, Ando Y, Kusano E, Asano Y. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 2001; 281: F114–F122
   PubMed Web of Science ®Google Scholar
• Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 2001; 55: 605–611
   PubMed Web of Science ®Google Scholar
• Thomas GN, Tomlinson B, Critchley JA. Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 2000; 36: 177–182
   PubMed Web of Science ®Google Scholar
• Kren V, Pravenec M, Lu S, Krenova D, Wang JM, Wang N, Merriouns T, Wong A, St Lezin E, Lau D, Szpirer C, Szpirer J, Kurtz TW. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest 1997; 99: 577–581
   PubMed Web of Science ®Google Scholar
• Hellstrand M, Danielsen EA, Steen VM, Ekman A, Eriksson E, Nilsson CL. The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 2004; 41: 867–871
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Okuyama Y, Toru M, Arinami T. Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 2000; 5: 433–438
   PubMed Web of Science ®Google Scholar
• Pettersson-Fernholm KJ, Forsblom CM, Perola M, Fagerudd JA, Groop PH. FinnDiane Study Group. Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 2004; 19: 1432–1436
   PubMed Web of Science ®Google Scholar
• Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, Pocchiari F, Felder RA, Eisner GM, Jose PA. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 1998; 102: 493–498
   PubMed Web of Science ®Google Scholar
• Staudacher T, Pech B, Tappe M, Gross G, Muhlbauer B, Luippold G. Arterial blood pressure and renal sodium excretion in dopamine D3 receptor knockout mice. Hypertens Res 2007; 30: 93–101
   PubMed Web of Science ®Google Scholar
• Armando I, Wang X, Jones JE, Asico LD, Jose PA. Impaired response to chronic sodium loading in dopamine D3 receptor deficient mice. Am J Hypertens 2005; 18: 126A, abstract
   Web of Science ®Google Scholar
• Ladines CA, Zeng C, Asico LD, Sun X, Pocchiari F, Semeraro C, Pisegna J, Wank S, Yamaguchi I, Eisner GM, Jose PA. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1071–R1078
   PubMed Web of Science ®Google Scholar
• Wang X, Armando I, Luo Y, Pascua A, Villar VA, Asico L, Jones JE, Escano CS, Friedman PA, Jose PA. Dopamine D3 receptors directly regulate NHE3 in renal proximal tubules. J Am Soc Nephrol 2007; 18: 597A, abstract
   Google Scholar
• Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 2001; 71: 70–77
   PubMed Web of Science ®Google Scholar
• Sen S, Nesse R, Sheng L, Stoltenberg SF, Gleiberman L, Burmeister M, Weder AB. Association between a dopamine-4 receptor polymorphism and blood pressure. Am J Hypertens 2005; 18: 1206–1210
   PubMed Web of Science ®Google Scholar
• Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, Eisner GM, Grandy DK, Carey RM, Soares-da-Silva P, Jose PA. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension. 2006; 47: 288–295
   Google Scholar
• Everett PB, Senogles SE. D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neurosci Lett 2004; 371: 34–39
   PubMed Web of Science ®Google Scholar
• Carvey PM, McGuire SO, Ling ZD. Neuroprotective effects of D3 dopamine receptor agonists. Parkinsonism Relat Disord 2001; 7: 213–223
   PubMed Web of Science ®Google Scholar
• Okada Y, Sakai H, Kohiki E, Suga E, Yanagisawa Y, Tanaka K, Hadano S, Osuga H, Ikeda JE. A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J Cereb Blood Flow Metab 2005; 25: 794–806
   PubMed Web of Science ®Google Scholar
• Ishige K, Chen Q, Sagara Y, Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci 2001; 21: 6069–6076
   PubMed Web of Science ®Google Scholar
• Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999; 27: 612–616
   PubMed Web of Science ®Google Scholar
• Bianchi P, Seguelas MH, Parini A, Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 2003; 14: 855–862
   PubMed Web of Science ®Google Scholar
• Cantuti-Castelvetri I, Joseph JA. Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss. Free Radic Biol Med 1999; 27: 1393–1404
   PubMed Web of Science ®Google Scholar
• Wersinger C, Prou D, Vernier P, Sidhu A. Modulation of dopamine transporter function by α-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 2003; 17: 2151–2153
   PubMed Web of Science ®Google Scholar
• Xia XG, Schmidt N, Teismann P, Ferger B, Schulz JB. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J Neurochem 2001; 79: 63–70
   PubMed Web of Science ®Google Scholar
• Gassen M, Glinka Y, Pinchasi B, Youdim MB. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur J Pharmacol 1996; 308: 219–225
   PubMed Web of Science ®Google Scholar
• Banday AA, Lau YS, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008; 51: 367–375
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Siragy HM, Felder RA, Carey RM. Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension 1997; 29: 228–234
   PubMed Web of Science ®Google Scholar
• Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA. The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol 2007; 292: H2083–H2092
   PubMed Web of Science ®Google Scholar
• Simão S, Fraga S, Jose PA, Soares-da-Silva P. Oxidative stress plays a permissive role in alpha2-adrenoceptor-mediated events in immortalized SHR proximal tubular epithelial cells. Mol Cell Biochem 2008; 315(1–2)31–39
   PubMed Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Reactive oxygen species and hypertension: a complex association. Antioxid Redox Signal 2008; 10: 1041–1044
   PubMed Web of Science ®Google Scholar
• Pinto V, Pinho MJ, Hopfer U, Jose PA, Soares-da-Silva P. Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells. Mol Cell Biochem 2008; 310: 191–201
   PubMed Web of Science ®Google Scholar
• Zeng C, Villar VA, Eisner GM, Williams SM, Felder RA, Jose PA. G protein-coupled receptor kinase 4. Role in blood pressure regulation. Hypertension 2008; 51: 1449–1455
   PubMed Web of Science ®Google Scholar